Back

Risk of early device-related thrombosis in post-Watchman cases on low-dose oral-anticoagulation versus dual-antiplatelet therapy

14 April 2026 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and stroke Oral Anticoagulation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sanghamitra Mohanty

St. David's Medical Center, Austin (United States of America)

6 More presentations in this session

Presentation thumbnail
Procedural and clinical outcomes after left atrial appendage occlusion in patients with preprocedural sludge or thrombus: a single-center experience
Doctor H. Alessandrini (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
From prescription to outcome: real-world utilization of direct oral anticoagulants in atrial fibrillation across Europe
Doctor R. Salguero-Bodes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Left atrial appendage occlusion with prior thrombus under OAC: feasibility and safety in a case series of patients with LA dilation and impaired atrial function
Miss F. Beisegel (Berlin, DE) Doctor D. Schoeppenthau (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Left atrial size-based anticoagulation discontinuation after catheter ablation for atrial fibrillation: a post-hoc analysis of the ALONE-AF Trial
Doctor D. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Long-term efficacy and safety of left atrial appendage closure with WATCHMAN in Japanese nonvalvular atrial fibrillation patients
Doctor M. Nakano (Chiba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and stroke

The Event

Event poster

EHRA 2026

14 April 2026 12:30 CET
You may be interested in
thumbnail
Congress Session
Outcomes and strategies in left atrial appendage closure
thumbnail
Congress Presentation
Anti-thrombotic regimen post-left atrial appendage closure
thumbnail
Congress Presentation
What is the optimal anticoagulation/antiplatelet strategy following left atrial appendage closure?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources